One clinical research of glypican-3 (GPC3) peptide vaccine in the treatment of HCC patients revealed that GPC3 peptide vaccine had good tolerance and anti-tumor effect, as well as could prolong the overall survival time of patients (95). Here, GPC3 is linked to hepatocellular carcinoma.